Immunai combines comprehensive, multi-omic single cell genomics with cutting edge machine learning algorithms to enable high resolution profiling of the immune system, at industrial scale, with rapid turnaround.

Our platform is used to advance research and development in checkpoint blockade, cancer cell therapy, and cancer vaccines.

We partner with academic research institutions, biopharmaceutical players, and biotechs to explore new indications and additional high value applications of our technology and data.

Home page of this offering   provided by Immunai